Company Name, Ticker, Industry, else..

Syros Pharmaceuticals Inc (SYRS)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

SYRS's Revenue Growth by Quarter and Year

Syros Pharmaceuticals Inc 's Revenue results by quarter and year

Select the Comparisons :

None ▼

Select the Ratio:

Revenue Growth Y/Y▼

None ▼

Revenue Growth Y/Y▼

SYRS Revenue (in millions $)		FY 2022	FY 2021	FY 2020	FY 2019
IV Quarter	December	-0.75	7.80	5.70	0.51
III Quarter	September	3.89	5.70	3.83	0.56
II Quarter	June	6.28	5.16	3.19	0.46
I Quarter	March	5.47	4.83	2.38	0.45
FY		14.89	23.49	15.10	1.98

SYRS Revenue forth quarter 2022 Y/Y Growth Comment

Syros Pharmaceuticals Inc in the forth quarter 2022 recorded of $ -0.75 millions.

Looking into forth quarter 2022 results within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue growth. While Syros Pharmaceuticals Inc ' s Revenue no change of % ranks overall at the positon no. 1302 in the forth quarter 2022.

SYRS Revenue ( Y/Y Growth %)		2022	2021	2020	2019
IV Quarter	December	-	36.84 %	1017.65 %	-42.7 %
III Quarter	September	-31.75 %	48.83 %	583.93 %	36.59 %
II Quarter	June	21.71 %	61.76 %	593.48 %	21.05 %
I Quarter	March	13.25 %	102.94 %	428.89 %	21.62 %
FY		-36.63 %	55.56 %	662.63 %	-3.41 %

Financial Statements
Syros Pharmaceuticals Inc 's forth quarter 2022 Revenue	$ -0.75 millions	SYRS's Income Statement
Syros Pharmaceuticals Inc 's forth quarter 2021 Revenue	$ 7.80 millions	Quarterly SYRS's Income Statement
New: More SYRS's historic Revenue Growth >>

SYRS Revenue (Quarter on Quarter Growth %)		2022	2021	2020	2019
IV Quarter	December	-	36.84 %	48.83 %	-8.93 %
III Quarter	September	-38.06 %	10.47 %	20.06 %	21.74 %
II Quarter	June	14.81 %	6.83 %	34.03 %	2.22 %
I Quarter	March	-29.87 %	-15.26 %	366.67 %	-49.44 %
FY (Year on Year)		-36.63 %	55.56 %	662.63 %	-3.41 %

Explore SYRS Customer Growth by Product and Service >> Back to SYRS Growth rate Comparisons >>

Revenue forth quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#62
Healthcare Sector	#159
Overall	#1302

Revenue Y/Y Growth Statistics
High	Average	Low
661.5 %	154.84 %	-36.65 %
(Dec 31 2020)		(Dec 31 2022)

Revenue forth quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#62
Healthcare Sector	#159
Overall	#1302

Revenue Y/Y Growth Statistics
High	Average	Low
661.5 %	154.84 %	-36.65 %
(Dec 31 2020)		(Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Syros Pharmaceuticals Inc 's Q/Q Revenue Growth

Revenue Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

SYRS's IV. Quarter Q/Q Revenue Comment

Recent accomplishment of -0.75 millions by Syros Pharmaceuticals Inc come out even worse if you take a look at 3.89 millions a quarter before.

Within Major Pharmaceutical Preparations industry Syros Pharmaceuticals Inc achieved highest sequential Revenue growth. While Syros Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is .

Revenue Q/Q Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue Q/Q Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Revenue Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

SYRS's IV. Quarter Q/Q Revenue Comment

Current of -0.75 millions by Syros Pharmaceuticals Inc come out even worse if you take a look at 3.89 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Syros Pharmaceuticals Inc achieved highest sequential Revenue growth. While Syros Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is .

Syros Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year

Revenue TTM Growth	12 Months Ending (Dec 31 2022)	12 Months Ending (Sep 30 2022)	12 Months Ending (Jun 30 2022)	12 Months Ending (Mar 31 2022)	12 Months Ending (Dec 31 2021)
Cumulative Revenue 12 Months Ending	$ 14.88	$ 23.44	$ 25.24	$ 24.13	$ 23.49
Y / Y Revenue Growth (TTM)	-36.65 %	9.6 %	29.35 %	37.55 %	55.62 %
Year on Year Revenue Growth Overall Ranking	# 261	# 1644	# 930	# 978	# 433
Seqeuential Revenue Change (TTM)	-36.51 %	-7.15 %	4.62 %	2.72 %	9.84 %
Seq. Revenue Growth (TTM) Overall Ranking	# 1302	# 2993	# 1279	# 2008	# 700

New: More SYRS's historic Revenue Growth >>

Cumulative Revenue growth Comment

For the 12 months ended Dec 31 2022 Syros Pharmaceuticals Inc reported a drop in Revenue by -36.65% year on year, to $15 millions, compare to the 9.6% growth at Sep 30 2022.

In the Healthcare sector 47 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 261, from total ranking in previous quarter at 1644.

Revenue TTM Q/Q Growth Statistics
High	Average	Low
661.5 %	154.84 %	-36.65 %

Revenue TTM Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 62
Healthcare Sector	# 48
Overall	# 261

Revenue TTM Y/Y Growth Statistics
High	Average	Low
661.5 %	154.84 %	-36.65 %

Revenue TTM Q/Q Growth Company Ranking
Within:	No.
Industry	# 62
Sector	# 159
S&P 500	# 1302

Cumulative Revenue growth Comment

Revenue TTM Q/Q Growth Statistics
High	Average	Low
661.5 %	154.84 %	-36.65 %

Revenue TTM Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 62
Healthcare Sector	# 48
Overall	# 261

Revenue TTM Y/Y Growth Statistics
High	Average	Low
661.5 %	154.84 %	-36.65 %

Revenue TTM Q/Q Growth Company Ranking
Within:	No.
Industry	# 62
Sector	# 159
S&P 500	# 1302

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SYRS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SYRS's Competitors
Revenue Growth for Syros Pharmaceuticals Inc 's Suppliers
Revenue Growth for SYRS's Customers

You may also want to know
SYRS's Annual Growth Rates	SYRS's Profitability Ratios	SYRS's Asset Turnover Ratio	SYRS's Dividend Growth
SYRS's Roe	SYRS's Valuation Ratios	SYRS's Financial Strength Ratios	SYRS's Dividend Payout Ratio
SYRS's Roa	SYRS's Inventory Turnover Ratio	SYRS's Growth Rates	SYRS's Dividend Comparisons

Companies with similar Revenue drop for the quarter ending Dec 31 2022 within Healthcare Sector	Y/Y Change %	Revenue for the quarter ending Dec 31 2022
Bausch Health Companies Inc	-0.14%	$ -0.137 millions
Bio rad Laboratories Inc	-0.34%	$ -0.339 millions
National Research Corporation	-0.40%	$ -0.402 millions
Asensus Surgical Inc	-0.48%	$ -0.485 millions
Teleflex Incorporated	-0.51%	$ -0.514 millions
Chemed Corporation	-0.85%	$ -0.851 millions
Fonar Corporation	-0.91%	$ -0.911 millions
Davita Inc	-0.92%	$ -0.920 millions
Syneos Health Inc	-0.98%	$ -0.984 millions
Accuray Incorporated	-1.30%	$ -1.303 millions
Pliant Therapeutics Inc	-1.70%	$ -1.701 millions
Royalty Pharma Plc	-1.73%	$ -1.729 millions
Integra Lifesciences Holdings Corp	-1.85%	$ -1.850 millions
Novartis Ag	-1.98%	$ -1.984 millions
Theravance Biopharma inc	-1.99%	$ -1.987 millions
Orthofix Medical Inc	-2.27%	$ -2.267 millions
Travere Therapeutics Inc	-2.41%	$ -2.412 millions
Heska Corporation	-2.54%	$ -2.542 millions
Sangamo Therapeutics Inc	-2.70%	$ -2.701 millions
Glaukos Corp	-2.75%	$ -2.748 millions
Community Health Systems Inc	-2.85%	$ -2.846 millions
West Pharmaceutical Services Inc	-3.02%	$ -3.024 millions
Petmed Express Inc	-3.04%	$ -3.042 millions
Novocure Limited	-3.59%	$ -3.591 millions
Lhc Group Inc	-4.33%	$ -4.329 millions
Innovage Holding Corp	-4.50%	$ -4.502 millions
Hyperfine Inc	-4.81%	$ -4.813 millions
Bristol myers Squibb Company	-4.83%	$ -4.831 millions
Central Garden and Pet Co	-5.10%	$ -5.101 millions
Vanda Pharmaceuticals Inc	-5.20%	$ -5.200 millions


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar CRTO's Profile Stock Price CRTO's Financials Business Description Fundamentals Charts & Quotes CRTO's News Suppliers CRTO's Competitors Customers & Markets Economic Indicators CRTO's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

SYRS's Revenue Growth by Quarter and Year

SYRS Revenue (Quarter on Quarter Growth %)

Revenue TTM Growth